Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449338) titled 'Prospective Cohort Study of Response and Tolerability of Accelerated Intermittent Theta-burst Stimulation (1W-AiTBS)' on Feb. 26.
Study Type: Observational [Patient Registry]
Primary Sponsor: Vastra Gotaland Region
Condition:
Depression
Intervention:
Device: iTBS (intermittent theta-burst stimulation)
Recruitment Status: Not recruiting
Date of First Enrollment: March 1, 2026
Target Sample Size: 36
Countries of Recruitment:
Sweden
To know more, visit https://clinicaltrials.gov/study/NCT07449338
Published by HT Digital Content Services with permission from Health Daily Digest....